11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

TMINI Miniature Robotic System

FDA 510(k)
FDA Class 2 ·Neurology

CoRoent

FDA UDI
Nuvasive, Inc.·00887517631411·CoRoent Ant TLIF Ti, 14x13x28mm 15°

SYRINGE 50ML LL TIP 1ML

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code FMF·October 28, 2024

Mandible External Fixator - MR Conditional

FDA 510(k)
FDA Class 2 ·Dental

3M Comply Hydrogen Peroxide Indicator Tape 1228

FDA 510(k)
FDA Class 2 ·General Hospital

BD LUER-LOK¿ SYRINGE

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMF·December 19, 2022

SUMMIT POR TAPER SZ3 STD OFF

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC.·Product code LPH·September 12, 2011

GYNECARE TVT-AA ABDOMINAL

FDA Adverse Event
Injury ·ETHICON INC.·Product code OTN·November 11, 2014

KINETRA

FDA Adverse Event
Malfunction ·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code MHY·July 23, 2013

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012

OPTETRAK Comprehensive Knee System including OPTETRAK Logic RBK PS Tibial Components (Product Line: 02-012-38-XXXX). NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.

FDA Enforcement
Class II ·Ongoing·Exactech, Inc.·October 13, 2021